COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® to Present at the 2018 Bank of America Merrill Lynch Health Care Conference
07/05/2018
BOTHELL, Wash., May 07, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
International Stem Cell Corporation Granted Key Patent in US
07/05/2018
CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based biotechnology company developing novel [...]
Menlo Therapeutics Announces Senior Clinical Leadership Updates
07/05/2018
REDWOOD CITY, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]
Trading by management and close relations of management
07/05/2018
Read the full announcement in the attached file Attachment 2018_27_Trading_by_management_EN
Matinas BioPharma to Host Quarterly Update Conference Call
07/05/2018
Conference call with live audio webcast on Thursday, May 10th at 8:30 am EDT BEDMINSTER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical [...]
Samumed Presented Multiple Abstracts Supporting Potential Disease Modification at the Osteoarthritis Research Society International (OARSI) 2018 World Congress
07/05/2018
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt research and development, presented its most recent clinical and preclinical data for two of the company’s investigational Wnt pathway inhibitors [...]
Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
07/05/2018
Top-line Results Expected in the Third Quarter of 2018 REHOVOT, Israel, and BRIDGEWATER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), a clinical stage specialty pharmaceutical [...]
Daré Bioscience, Inc. Enters into Agreement to Acquire Product to Address Vulvar and Vaginal Atrophy in Hormone Receptor-Positive Breast Cancer Patients
07/05/2018
Agreement intends to broaden Company’s product portfolio within women’s reproductive health with novel clinical candidate, positioning Company with first in class candidates in contraception, sexual health and vaginal [...]
Biotech Industry Veteran Dietmar Berger, M.D., Ph.D., Joins Atara Biotherapeutics as Global Head of Research and Development
07/05/2018
Expanded R&D leadership team focused on rigorous late-stage clinical development and leveraging full potential of Atara’s technology platform SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara [...]
Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018
07/05/2018
Conference Call and Webcast Scheduled for Monday, May 14 at 8:00 a.m. Eastern Time YARDLEY, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, [...]
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
07/05/2018
TUCSON, Ariz. and HUNINGUE, France, May 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and [...]
Rexahn Reports First Quarter 2018 Financial Results
07/05/2018
ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
07/05/2018
The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system BrainsWay will be demonstrating the new [...]
Caladrius Biosciences to Participate at the 15th International Symposium on Cardiovascular Regeneration and Repair
07/05/2018
BASKING RIDGE, N.J. , May 07, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer
07/05/2018
With the designation of five targets, Pfizer nominates the maximum permitted under collaboration Collaboration moving toward candidate selection CAMBRIDGE, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd [...]
Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update
07/05/2018
IND for KB103 to treat dystrophic epidermolysis bullosa (DEB) cleared by FDA Patient enrollment in Phase 1/2 study of KB103 to begin in May 2018 at Stanford University Krystal Biotech’s KB103 receives Orphan Medicinal [...]
RedHill Biopharma Announces Last Patient Assessed for Primary Endpoint in RHB-104 Phase III Study for Crohn’s Disease
07/05/2018
Top-line results from the Phase III study with RHB-104 for Crohn’s disease are expected to be announced in approximately three months Worldwide sales of Crohn’s disease therapies are estimated to exceed $10 billion in [...]
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
07/05/2018
Fourth Quarter Net Income Increased 36% Fourth Quarter EPS $0.50 per share vs $0.37 per share DELRAY BEACH, Fla., May 07, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) today announced its financial [...]
Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma
07/05/2018
Duke Medical Center Opens for Patient Enrollment NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic [...]

Pages